Voveran TPM vs voltaren, page-15

No turps - we would be in the right poo if Novartis had locked us up globally on a pure royalty basis and then just shelved it to get rid of us. I am reliably informed that at this stage there is nothing preventing us from doing deals with whoever we like in the other territories. In fact as soon as we do one I wouldn't be too surprised to see Novartis on the phone fairly quickly. And yes turps that really is the issue there is no clear number 2 - it is Voltaren or a generic - Novartis is pretty much the only named brand with any market penetration. GC is right we need another big pharma that just wants to grab that $1bn market for themselves and I wouldn't have thought it wasn't a very hard sell when we have our own and Novartis' data to prove the claims.